Nonlymphocytic Acute myeloid leukemia
What Is Nonlymphocytic Acute Myeloid Leukemia?
Nonlymphocytic acute myeloid leukemia (NALM) is a rare form of leukemia that affects the white blood cells. It is the most common type of acute myeloid leukemia, accounting for 15 to 20 percent of all cases. NALM can occur in both adults and children and is more prevalent in males. This type of leukemia begins in the bone marrow and can spread to other parts of the body, such as the spleen and liver.
What Are The Symptoms Of NALM?
NALM is difficult to diagnose in its early stages due to its non-specific symptoms like fatigue, fever, easy bruising and bleeding, and weight loss. Additional symptoms may include headaches, night sweats, anemia, and enlarged lymph nodes or spleen.
How Is NALM Diagnosed?
NALM is typically diagnosed through a series of tests, such as a complete blood count (CBC), bone marrow procedure, and genetic testing of the bone marrow. The results of these tests will help the medical team determine how advanced the NALM is.
Treatment Options for NALM
Treatment options for NALM depend on the stage of the disease. Treatment typically includes:
- Chemotherapy
- Radiation therapy
- Stem cell transplant
- Targeted therapy
The goal of treatment is to control the NALM and prevent the progression of the disease. It is important for patients to speak with their doctor about the available treatment options for their individual case.
What Is The Prognosis For NALM?
The prognosis for NALM depends on several factors, such as the patient's age and overall health, the extent of the disease, and the response to treatment. With successful treatment, the overall five-year survival rate can be as high as 40 to 50 percent. Although there is no way to predict the outcome for each individual case, the prognosis for NALM is generally good with timely diagnosis and treatment.